Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 2Lymphoma 2Sarcoma 1Preleukemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Osteosarcoma 1Neoplasms, Plasma Cell 1Neoplasms by Histologic Type 1Neoplasms 1Myelodysplastic Syndromes 1Mobility Limitation 1Melanoma 1Lymphoproliferative Disorders 1Lymphoma, B-Cell, Marginal Zone 1Lymphatic Diseases 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphoid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Leukemia, B-Cell 1Leukemia 1Kidney Neoplasms 1Immunoproliferative Disorders 1Immune System Diseases 1Hematologic Diseases 1Head and Neck Neoplasms 1Esophageal Neoplasms 1

Interventions

Specimen Handling 3Standard of Care 2Practice Guidelines as Topic 2Patient Reported Outcome Measures 1Exercise Therapy 1Educational Status 1Data Collection 1CVnCoV COVID-19 vaccine 1COH04S1 COVID-19 vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
COVID-19 × Patient Reported Outcome Measures × 90 days × Clear all
NCT05831787 2026-05-18

COSMIC

ASH Research Collaborative

Completed
201 enrolled 15 charts
Plasma cell

COVID-19, Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡